James Feuille - Jun 13, 2025 Form 4 Insider Report for Chime Financial, Inc. (CHYM)

Role
Director
Signature
/s/ Theresa Bloom. by power of attorney
Stock symbol
CHYM
Transactions as of
Jun 13, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 07:41 PM
Previous filing
Jun 11, 2025
Next filing
Aug 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feuille James Director C/O CHIME FINANCIAL, INC., 101 CALIFORNIA STREET, SUITE 500, SAN FRANCISCO /s/ Theresa Bloom. by power of attorney 2025-06-13 0001318214

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHYM Common Stock Conversion of derivative security +23.8M 23.8M Jun 13, 2025 See footnote F1, F2, F3, F4, F5
transaction CHYM Common Stock Other -23.8M -100% 0 Jun 13, 2025 See footnote F5, F6
transaction CHYM Class A Common Stock Other +23.8M 23.8M Jun 13, 2025 See footnote F4, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHYM Series A Preferred Stock Conversion of derivative security -16.2M -100% 0 Jun 13, 2025 Common Stock 16.3M See footnote F1, F5, F7
transaction CHYM Series A-2 Preferred Stock Conversion of derivative security -5.07M -100% 0 Jun 13, 2025 Common Stock 5.07M See footnote F2, F5, F8
transaction CHYM Series B Preferred Stock Conversion of derivative security -2.39M -100% 0 Jun 13, 2025 Common Stock 2.39M See footnote F3, F5, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock automatically converted into Common Stock on a 1.0089020772-for-1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO") and had no expiration date.
F2 Each share of Series A-2 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date.
F3 Each share of Series B Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date.
F4 These shares are held as follows: (i) 7,221,106 shares held by Crosslink Crossover Fund VI, L.P. ("CO VI"); (ii) 10,782,501 shares held by Crosslink Ventures VII, L.P. ("CV VII"); (iii) 4,620,340 shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B"); and (iv) 1,142,307 shares held by Crosslink Bayview VII, LLC ("CB VII").
F5 The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
F6 Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the IPO.
F7 These shares were held as follows: (i) 6,555,280 shares held by CO VI; (ii) 6,263,780 shares held by CV VII; (iii) 2,684,056 shares held by CV VII-B; and (iv) 663,590 shares held by CB VII.
F8 These shares were held as follows: (i) 2,908,030 shares held by CV VII; (ii) 1,246,100 shares held by CV VII-B; (iii) 607,470 shares held by CO VI; and (iv) 308,080 shares held by CB VII.
F9 These shares were held as follows: (i) 1,554,930 shares held by CV VII; (ii) 666,290 shares held by CV VII-B; and (iii) 164,730 shares held by CB VII.